Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Rueda

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Gastroenterologia Y Hepatologia|February 5, 2021
Nutricional habits in patients with inflammatory bowel disease: perception of patients and health professionalsCristina Suárez Ferrer, María Ángeles Ruiz Ramírez, María Sánchez Azofra, et al.
Inflammatory Bowel Diseases|June 5, 2020
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National SurveyEduardo Martin Arranz, Cristina Suarez Ferrer, Laura García Ramírez, et al.
Scandinavian Journal of Gastroenterology|December 15, 2022
Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trialJose Luis Rueda García, Cristina Suárez Ferrer, Eduardo Martín-Arranz, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel diseaseCarmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, et al.
Revista Espanola De Enfermedades Digestivas|December 2, 2020
Prognostic value of ultrasound activity and parietal healing in patients with Crohn's diseaseCristina Suárez Ferrer, Joaquín Poza Cordón, Olivia Crivillén Anguita, et al.
Journal of Clinical Medicine|March 14, 2026
Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF TherapyClara Amiama Roig, Cristina Suárez-Ferrer, José Luis Rueda García, et al.
Therapeutic Advances in Gastroenterology|March 20, 2025
Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn's DiseaseJosé Luis Rueda García, Cristina Suárez-Ferrer, Clara Amiama Roig, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 17, 2021
The Circadian Clock Gene, Bmal1, Regulates Intestinal Stem Cell Signaling and Represses Tumor InitiationKyle Stokes, Malika Nunes, Chantelle Trombley, et al.
Revista Espanola De Enfermedades Digestivas|January 16, 2023
Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective studyMaría Dolores Martín Arranz, Laura García-Ramírez, Eduardo Martín Arranz, et al.
Frontiers in Immunology|March 20, 2026
T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn's diseaseEduardo Martín Arranz, Laura García-Ramirez, Ana Van Den Rym, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Gastroenterologia Y Hepatologia|February 5, 2021
Nutricional habits in patients with inflammatory bowel disease: perception of patients and health professionalsCristina Suárez Ferrer, María Ángeles Ruiz Ramírez, María Sánchez Azofra, et al.
Inflammatory Bowel Diseases|June 5, 2020
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National SurveyEduardo Martin Arranz, Cristina Suarez Ferrer, Laura García Ramírez, et al.
Scandinavian Journal of Gastroenterology|December 15, 2022
Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trialJose Luis Rueda García, Cristina Suárez Ferrer, Eduardo Martín-Arranz, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel diseaseCarmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, et al.
Revista Espanola De Enfermedades Digestivas|December 2, 2020
Prognostic value of ultrasound activity and parietal healing in patients with Crohn's diseaseCristina Suárez Ferrer, Joaquín Poza Cordón, Olivia Crivillén Anguita, et al.
Journal of Clinical Medicine|March 14, 2026
Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF TherapyClara Amiama Roig, Cristina Suárez-Ferrer, José Luis Rueda García, et al.
Therapeutic Advances in Gastroenterology|March 20, 2025
Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn's DiseaseJosé Luis Rueda García, Cristina Suárez-Ferrer, Clara Amiama Roig, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 17, 2021
The Circadian Clock Gene, Bmal1, Regulates Intestinal Stem Cell Signaling and Represses Tumor InitiationKyle Stokes, Malika Nunes, Chantelle Trombley, et al.
Revista Espanola De Enfermedades Digestivas|January 16, 2023
Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective studyMaría Dolores Martín Arranz, Laura García-Ramírez, Eduardo Martín Arranz, et al.
Frontiers in Immunology|March 20, 2026
T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn's diseaseEduardo Martín Arranz, Laura García-Ramirez, Ana Van Den Rym, et al.
Pageof 8